Sekwon Jang, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Sun Biopharma
    Date added: 
    04/07/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    07/15/2022
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Iovance
    Date added: 
    04/07/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    11/08/2021
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Bayer
    Date added: 
    04/07/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    10/14/2021
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Macrogenics
    Date added: 
    04/07/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    08/09/2021
    Date reviewed: 
    11/01/2023
Return to 2023 Herbert Golomb, MD Melanoma and Cutaneous Oncology Primer